Patent assignee · US · COMPANY

Osteogenex, Inc.

4Patents
4Active
4Granted
45Portfolio score

Filing activity: Dec 21, 2007 → Oct 1, 2009 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8178099B2 Methods of altering bone growth by administration of sost or wise antagonist or agonist Chemistry; Metallurgy 40 Active
US8188065B2 Boldine compounds for promoting bone growth Human Necessities 2 Active
US8080575B2 Gamma-lactam compounds for promoting bone growth Human Necessities 0 Active
US8198292B2 Vinpocetine and eburnamonine derivatives for promoting bone growth, treating renal damage and cancer, and devices thereof Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.